MetLife, Inc. $MET Stock Holdings Lowered by Park Avenue Securities LLC

Park Avenue Securities LLC trimmed its holdings in shares of MetLife, Inc. (NYSE:MET) by 17.0% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 32,486 shares of the financial services provider’s stock after selling 6,647 shares during the period. Park Avenue Securities LLC’s holdings in MetLife were worth $2,676,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. Blue Trust Inc. boosted its stake in shares of MetLife by 3.6% during the 3rd quarter. Blue Trust Inc. now owns 3,585 shares of the financial services provider’s stock worth $295,000 after acquiring an additional 125 shares in the last quarter. Daymark Wealth Partners LLC raised its position in shares of MetLife by 4.2% during the third quarter. Daymark Wealth Partners LLC now owns 3,192 shares of the financial services provider’s stock worth $263,000 after purchasing an additional 130 shares during the period. Ignite Planners LLC lifted its holdings in shares of MetLife by 2.2% during the second quarter. Ignite Planners LLC now owns 6,366 shares of the financial services provider’s stock valued at $491,000 after purchasing an additional 136 shares during the last quarter. Legacy Capital Wealth Partners LLC boosted its position in shares of MetLife by 3.2% in the 2nd quarter. Legacy Capital Wealth Partners LLC now owns 4,355 shares of the financial services provider’s stock valued at $350,000 after purchasing an additional 137 shares during the period. Finally, Abound Wealth Management increased its stake in MetLife by 29.9% in the 3rd quarter. Abound Wealth Management now owns 635 shares of the financial services provider’s stock worth $52,000 after purchasing an additional 146 shares in the last quarter. Institutional investors own 94.99% of the company’s stock.

MetLife Trading Down 0.5%

Shares of NYSE:MET opened at $79.37 on Friday. The firm has a fifty day moving average of $78.77 and a two-hundred day moving average of $79.02. The company has a quick ratio of 0.18, a current ratio of 0.18 and a debt-to-equity ratio of 0.54. MetLife, Inc. has a 12-month low of $65.21 and a 12-month high of $88.09. The firm has a market capitalization of $52.30 billion, a P/E ratio of 14.95, a price-to-earnings-growth ratio of 0.72 and a beta of 0.76.

MetLife (NYSE:MET) last announced its quarterly earnings data on Wednesday, November 5th. The financial services provider reported $2.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.30 by $0.07. MetLife had a return on equity of 21.00% and a net margin of 5.30%.The business had revenue of $12.46 billion during the quarter, compared to analyst estimates of $18.64 billion. During the same period last year, the company earned $1.95 earnings per share. MetLife’s quarterly revenue was down 5.9% compared to the same quarter last year. On average, equities analysts expect that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

MetLife Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 10th. Investors of record on Tuesday, February 3rd will be paid a $0.5675 dividend. The ex-dividend date of this dividend is Tuesday, February 3rd. This represents a $2.27 annualized dividend and a dividend yield of 2.9%. MetLife’s payout ratio is presently 42.75%.

Wall Street Analysts Forecast Growth

MET has been the subject of a number of analyst reports. Evercore ISI set a $97.00 price objective on shares of MetLife and gave the company an “in-line” rating in a research note on Tuesday. Mizuho began coverage on shares of MetLife in a research report on Monday, December 15th. They issued an “outperform” rating and a $101.00 price target for the company. UBS Group lowered their price objective on shares of MetLife from $95.00 to $94.00 and set a “buy” rating on the stock in a research report on Thursday. Morgan Stanley set a $101.00 target price on MetLife and gave the company an “overweight” rating in a report on Monday, December 15th. Finally, Piper Sandler cut MetLife from an “overweight” rating to a “neutral” rating and set a $84.00 target price for the company. in a research report on Friday, September 19th. Two research analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, MetLife has a consensus rating of “Moderate Buy” and a consensus target price of $95.08.

MetLife Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.